At different cascade levels, the specific targeting of lymphangiogenesis via inhibiting VEGF-C/VEGFR-3 signaling pathway is fundamentally depending on the profile of organ-associated LEC specialization and heterogeneity for preventing tumor progression and metastasis. This evidence concerns the gene FLT4 and neoplasm.